Log in
Enquire now
‌

US Patent 9597314 Beta-lactamylalkanoic acids for treating premenstrual disorders

Patent 9597314 was granted and assigned to Azevan Pharmaceuticals on March, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

0-lactamyl alkanoic acids are described. Methods for treating various premenstrual disorders using or more β-lactamyl alkanoic acids are also described.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9597314 Beta-lactamylalkanoic acids for treating premenstrual disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.